Compare with INDRAPRASTHA MEDICAL - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs INDRAPRASTHA MEDICAL - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS INDRAPRASTHA MEDICAL KRSNAA DIAGNOSTICS/
INDRAPRASTHA MEDICAL
 
P/E (TTM) x - 13.6 - View Chart
P/BV x 9.5 2.7 351.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KRSNAA DIAGNOSTICS   INDRAPRASTHA MEDICAL
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
INDRAPRASTHA MEDICAL
Mar-21
KRSNAA DIAGNOSTICS/
INDRAPRASTHA MEDICAL
5-Yr Chart
Click to enlarge
High RsNA70 0.0%   
Low RsNA31 0.0%   
Sales per share (Unadj.) Rs998.866.9 1,492.8%  
Earnings per share (Unadj.) Rs284.50.3 111,982.3%  
Cash flow per share (Unadj.) Rs342.13.9 8,796.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %NM0- 
Book value per share (Unadj.) Rs355.529.8 1,194.6%  
Shares outstanding (eoy) m6.5091.67 7.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x00.8 0.0%   
Avg P/E ratio x0199.2 0.0%  
P/CF ratio (eoy) x013.0 0.0%  
Price / Book Value ratio x01.7 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m04,639 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2961,977 15.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,4926,134 105.8%  
Other income Rs m1227 1,804.7%   
Total revenues Rs m6,6156,141 107.7%   
Gross profit Rs m3,466403 860.7%  
Depreciation Rs m374333 112.4%   
Interest Rs m25933 777.6%   
Profit before tax Rs m2,95543 6,888.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,10520 5,638.9%   
Profit after tax Rs m1,84923 7,940.3%  
Gross profit margin %53.46.6 813.1%  
Effective tax rate %37.445.7 81.9%   
Net profit margin %28.50.4 7,501.7%  
BALANCE SHEET DATA
Current assets Rs m2,4811,414 175.5%   
Current liabilities Rs m1,8381,159 158.6%   
Net working cap to sales %9.94.2 238.2%  
Current ratio x1.41.2 110.6%  
Inventory Days Days252 1,081.6%  
Debtors Days Days4140 101.6%  
Net fixed assets Rs m3,5642,905 122.7%   
Share capital Rs m2,489917 271.5%   
"Free" reserves Rs m-1781,811 -9.9%   
Net worth Rs m2,3102,728 84.7%   
Long term debt Rs m1,6800-   
Total assets Rs m6,0454,320 140.0%  
Interest coverage x12.42.3 542.1%   
Debt to equity ratio x0.70-  
Sales to assets ratio x1.11.4 75.6%   
Return on assets %34.91.3 2,659.7%  
Return on equity %80.00.9 9,373.7%  
Return on capital %80.52.8 2,881.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m0620 0.0%   
Fx outflow Rs m052 0.0%   
Net fx Rs m0568 0.0%   
CASH FLOW
From Operations Rs m1,026279 367.6%  
From Investments Rs m-611-202 303.2%  
From Financial Activity Rs m308-31 -980.0%  
Net Cashflow Rs m72346 1,574.6%  

Share Holding

Indian Promoters % 27.4 49.4 55.4%  
Foreign collaborators % 0.0 1.6 -  
Indian inst/Mut Fund % 34.6 0.1 69,160.0%  
FIIs % 4.4 0.0 14,800.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 49.0 148.2%  
Shareholders   75,065 58,001 129.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   FORTIS HEALTHCARE    THYROCARE TECHNOLOGIES    METROPOLIS HEALTHCARE    DR. LAL PATHLABS    KIMS    



Today's Market

4 Reasons Why Sensex Plunged 634 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

INDRAPRASTHA MEDICAL 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of INDRAPRASTHA MEDICAL for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of INDRAPRASTHA MEDICAL. Also includes updates on the valuation of INDRAPRASTHA MEDICAL.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Jan 20, 2022 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS 8-QTR ANALYSIS

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS